Immunotherapy for malignant tumors with focus on toll‐like receptors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for malignant tumors with focus on toll‐like receptors

Published:2019-03-27 Issue:1 Volume:16 Page:3-7
ISSN:1348-8643
Container-title:Oral Science International
language:en
Short-container-title:Oral Sci Int

Author:

Manome Yoko¹²,Suzuki Dai¹,Nishida Rie¹³,Yamada Atsushi¹,Miyamoto Yoichi¹,Funatsu Takahiro²,Kamijo Ryutaro¹

Affiliation:

1. Department of BiochemistrySchool of DentistryShowa University Shinagawa, Tokyo Japan

2. Division of Dentistry for Persons with DisabilitiesDepartment of Special Needs DentistryShowa University Dental Hospital Ota, Tokyo Japan

3. Division of AnesthesiologyDepartment of Perioperative MedicineShowa University Dental Hospital Ota, Tokyo Japan

Funder

Grant-in-Aid for Scientific Research (C) from JSPS

Private University Research Branding Project from MEXT

Grant-in-Aid for Challenging Exploratory Research from JSPS

MEXT-Supporting Program for the Strategic Research Foundation at Private Universities

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/osi2.1011

Reference35 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice C;JAMA Oncol,2017

2. Safety, activity, and immune correlates of anti‐PD‐1 antibody in cancer;Topalian SL;N Engl J Med,2012

3. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi FS;N Engl J Med,2010

4. Manipulating immune cells for adoptive immunotherapy of cancer;Darcy PK;Curr Opin Immunol,2014

5. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case‐control study;Velayos FS;Gastroenterology,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Toll-Like Receptors in Cancer Immunotherapy;Handbook of Cancer and Immunology;2023

2. The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy;Medicine in Drug Discovery;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3